The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best weight ...

However, its gross margin declined by 150 bps on-year to 62.2 percent as a result of a change in the product mix. ICICI Securities has raised its estimates for GSK Pharma's FY25-26 earnings per ...

The company reported strong performance across key product portfolios ... In the vaccines segment, GlaxoSmithKline Pharmaceuticals maintained leadership in the self-pay private market for ...

a second-generation anti-histamine and research product of UCB Pharma (Belgium) was launched under a co-marketing agreement. In the same year Glaxo received recognition from the Ministry of ...

GSK Pharma shares gained by 20 percent on Monday ... The decline was a result of a change in the product mix. For the period under review, the company's EBITDA grew 29.8 percent YoY, to reach ...

Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million. The offer price ...

GlaxoSmithKline Pharmaceuticals Ltd (GSK ... The quarter saw strong performance across key product portfolios. Flagship brands within the general medicines portfolio including Augmentin, Ceftum ...

GSK plc (NYSE:GSK) specializes in pharmaceuticals, vaccines, and consumer health products, with a strong focus on immunology.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.